中国组织工程研究

中国组织工程研究 ›› 2012, Vol. 16 ›› Issue (2): 315-319.doi: 10.3969/j.issn.1673-8225.2012.02.029

• 组织构建基础实验 basic experiments in tissue construction • 上一篇    下一篇

MicroRNA-125a质粒表达载体的构建及其表达活性★

张  涛，李  东，李  华，高  辉   

  1. 解放军成都军区总医院肿瘤诊治中心，四川省成都市  610083
  • 收稿日期:2011-07-11 修回日期:2011-10-18 出版日期:2012-01-08 发布日期:2012-01-08
  • 作者简介:张涛★，男，1963年生，四川省内江市人，汉族，1990年解放军第三军医大学毕业，硕士，主任医师，主要从事肿瘤内科、肝癌干细胞研究工作。

Construction and expressing activity of microRNA-125a plasmid expression vectors 

Zhang Tao, Li Dong, Li Hua, Gao Hui   

  1. Center of Tumor Diagnosis and Treatment, Chengdu Millitary General Hospital of Chinese PLA, Chengdu  610083, Sichuan Province, China
  • Received:2011-07-11 Revised:2011-10-18 Online:2012-01-08 Published:2012-01-08
  • About author:Zhang Tao★, Master, Chief physician, Center of Tumor Diagnosis and Treatment, Chengdu Millitary General Hospital of Chinese PLA, Chengdu 610083, Sichuan Province, China zhangato269@126.com

PDF

464

摘要：

背景：pSuper是一种非编码RNA的真核表达载体，可在细胞质内表达miRNA前体，经过细胞自身的Dicer酶切后形成miRNA成熟体，其过程能够完全模仿细胞内源性miRNA形成过程。因此，利用pSuper表达载体构建一种肝癌抑制性miRNA：miR-125a的表达载体，为下一步研究其抗癌机制奠定了基础。
目的：构建miR-125a的真核表达质粒pSuper-miR-125a，并验证其表达miR-125a的效率和特异性。
方法：PCR扩增miR-125a前体(Pre-miR-125a)的目的片段，将其T-A克隆入pMD18-T过渡质粒载体，限制性内切酶切下目的片段，连接入pSuper质粒表达载体得到pSuper-miR-125a重组质粒；将重组质粒转染Hela细胞，miRNA定量PCR检测重组质粒表达miR-125a的效率和特异性。
结果与结论：成功将miR-125a前体(Pre-miR-125a)片段克隆入真核表达质粒pSuper H1启动子下游，获得pSuper-miR-125a重组表达质粒，转染该质粒进入Hela细胞后能够在细胞内高效和特异的表达miR-125a，进一步证明 pSuper真核表达质粒适合miRNA的表达研究。

关键词: 表达载体, MicroRNA-125a, 表达鉴定, pSuper, 质粒

Abstract:

BACKGROUND: pSuper is a kind of eukaryotic expression vectors of non-coding RNA. It expresses the precursor of miRNA in plasma, and then the precursor is cut by Dicer enzyme to produce mature miRNA. This process completely imitates the formation process of endogenous miRNA. In this study, pSuper is utilized to construct an expression vector of miR-125a, which could inhibit liver cancer. It provides basis for the further investigation on antitumor mechanism.
OBJECTIVE: To construct the eukaryotic plasmid pSuper-miR-125a expressing miR-125a and to confirm the expressing efficiency and specificity of miR-125a in the plasmid.
METHODS: Target fragments in the precursor of miR-125a (Pre-miR-125a) were amplified by PCR. The fragments were cloned into pMD18-T transition plasmid using T-A cloning method. The target fragments were cut by restriction enzyme and then connected to pSuper plasmid to construct recombinant plasmid pSuper-miR-125a. The recombinant plasmid was transfected into Hela cells. The expressing efficiency and specificity of miR-125a in the recombinant plasmid was detected by real-time PCR.
RESULTS AND CONCLUSION: The fragments in miR-125a precursor (Pre-miR -125a) were successfully cloned into the promoter downstream of eukaryotic expression plasmid pSuper H1. The recombinant expression plasmid pSuper-miR-125a was constructed. The plasmid expresses miR-125a effectively and specifically after transfeced into Hela cells. These findings confirm that the eukaryotic expression plasmid pSuper is suitable for the expression research of miRNA.

中图分类号: